rosiglitazone has been researched along with Subarachnoid Hemorrhage in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, YF; Chen, CM; Cherng, CH; Chuang, MY; Kuo, CY; Lin, BF; Wen, LL; Wong, CS; Wu, ZF | 1 |
| An, JY; Cheng, MF; Li, DD; Luo, XH; Song, JN; Sun, P; Zhao, YL | 1 |
| Chen, G; Chen, J; Gu, C; Li, J; Wang, Y; Wu, C; Yan, F | 1 |
| Cheng, HL; Shi, JX; Wu, Y; Xue, YJ; Yin, HX; Zhao, XD; Zhuang, Z | 1 |
| Cheng, HL; Huang, RQ; Shi, JX; Tang, K; Wu, Y; Yin, HX; Zhuang, Z | 1 |
5 other study(ies) available for rosiglitazone and Subarachnoid Hemorrhage
| Article | Year |
|---|---|
Rosiglitazone attenuates cerebral vasospasm and provides neuroprotection in an experimental rat model of subarachnoid hemorrhage.
Topics: Animals; Disease Models, Animal; Excitatory Amino Acid Transporter 2; Glutamic Acid; Neuroprotective Agents; Random Allocation; Rats; Rosiglitazone; Subarachnoid Hemorrhage; Thiazolidinediones; Vasospasm, Intracranial | 2014 |
The role of rosiglitazone in the proliferation of vascular smooth muscle cells after experimental subarachnoid hemorrhage.
Topics: Animals; Basilar Artery; Caveolin 1; Cell Proliferation; Disease Models, Animal; Immunohistochemistry; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Proliferating Cell Nuclear Antigen; Rats; Rats, Sprague-Dawley; Rosiglitazone; Subarachnoid Hemorrhage; Thiazolidinediones; Up-Regulation; Vasoconstriction; Vasodilator Agents; Vasospasm, Intracranial | 2014 |
Rosiglitazone attenuates early brain injury after experimental subarachnoid hemorrhage in rats.
Topics: Analysis of Variance; Animals; Blood-Brain Barrier; Brain Edema; Brain Injuries; Caspase 3; Cyclin D1; Disease Models, Animal; In Situ Nick-End Labeling; Male; Matrix Metalloproteinase 9; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Rosiglitazone; Subarachnoid Hemorrhage; Thiazolidinediones | 2015 |
Peroxisome proliferator-activated receptor gamma agonist rosiglitazone attenuates oxyhemoglobin-induced Toll-like receptor 4 expression in vascular smooth muscle cells.
Topics: Anilides; Animals; Cells, Cultured; Culture Media, Conditioned; Down-Regulation; Inflammation; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Oxyhemoglobins; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Subarachnoid Hemorrhage; Thiazolidinediones; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha; Vasodilator Agents; Vasospasm, Intracranial | 2010 |
Therapeutic potential of peroxisome proliferator-activated receptor γ agonist rosiglitazone in cerebral vasospasm after a rat experimental subarachnoid hemorrhage model.
Topics: Animals; Disease Models, Animal; Male; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Signal Transduction; Subarachnoid Hemorrhage; Thiazolidinediones; Toll-Like Receptor 4; Vasodilator Agents; Vasospasm, Intracranial | 2011 |